Navigation Links
BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
Date:6/4/2008

MOUNTAIN VIEW, California, June 4 /PRNewswire-FirstCall/ -- BN ImmunoTherapeutics, Inc. has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer.

A Phase I/II safety and tolerability study in 18 male patients with non-metastatic as well as hormone-insensitive prostate cancer has begun enrolment in the US. Secondary objectives of the trial include examining the ability of the vaccine to induce prostate antigen-specific immune responses, as well as clinical anti-tumor activity. Preliminary data is expected during second half year 2009.

The therapeutic vaccine, based on the company's MVA-BN(R) technology, is designed to generate cellular and humoral immune responses to PSA and PAP (prostate specific antigen and prostatic acid phosphatase), which are both well-known prostate cancer tumor targets.

Prostate cancer is, along with breast cancer, in the top three cancer market, each with more than 500,000 new diagnosed incidents globally per year and only limited treatment options.

Reiner Laus, MD, President & CEO of BN ImmunoTherapeutics said: "The initiation of clinical studies with our therapeutic prostate cancer vaccine advances our cancer portfolio and with both breast and prostate cancer vaccines in clinical development, we have now strengthened the cancer business area, which is an essential part of our group strategy going forward."

Located in Mountain View, California, BN ImmunoTherapeutics is a subsidiary of Bavarian Nordic, headquartered in Denmark.

Bavarian Nordic A/S is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology, MVA-BN(R), has been demonstrated in clinical trials to be one of the
'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
2. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
3. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
4. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
5. ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
6. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
7. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
8. EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting
9. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
10. Valor Medical Reports Early Clinical Results of New Technology to Treat Cerebral Aneurysms
11. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)....,Nov.25/PRNewswire/--PraxisElectronicMedicalRecor...FamilyPhysicians,(AAFP)FamilyPracticeManagement(FP...quality,healthmaintenance,anddiseasemanagement,all...nked#1amongdoctorsindicatingtheirEMRhadapositiveef...kednumberoneinthecountryinprovidingexcellenttraini...
(Date:11/25/2009)...ov.25/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasda...ttedtodiscovering,developingandcommercializingnove...ltsforthefiscalyearendedSeptember30,2009.AtSeptemb...valentsandshortterminvestments. ,, PipelineUpd...2bTrial ,, InlateNovember2009,anindependentDa...
(Date:11/25/2009)...,Nov.25/PRNewswire/--TheFDAgrantedtraditionalappro...eosidereversetranscriptaseinhibitor(NNRTI).INTELEN...ment-experiencedadultswhoareexperiencingvirologicf...tiretroviral(ARV)agents.Thetraditionalapprovalisba...ndDUET-2.INTELENCEiscurrentlymarketedintheU.S.byTi...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference 13893 1PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference 13893 2DuPont Leader Says Increasing Food Production a Moral Imperative 13891 1DuPont Leader Says Increasing Food Production a Moral Imperative 13891 2DuPont Leader Says Increasing Food Production a Moral Imperative 13891 3Gerber Life Medicare Supplement Now Available Through Precision Senior Marketing 56382 1Gerber Life Medicare Supplement Now Available Through Precision Senior Marketing 56382 2
...ion Pharmaceuticals, Inc. (Nasdaq: TRBN ) announ...SCORPION(TM) multispecific therapeutic technology ...ation of Cancer Research (AACR) in Denver, April 1...gi-bin/prnh/20090320/TRUBIONLOGO ) , , The compan...and high potency of the bispecific CD79BxDR SCORPI...
...ands, April 16 The European,Association of Urolog...ientific information on randomised screening studi.... Based on the results of the European Randomised,...e EAU has formulated a,position statement regardin...sequent actions to be taken by health professional...
Other Medicine Technology:Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 3EAU Position Statement on Screening for Prostate Cancer 2
(Date:11/26/2009)... emotional rollercoaster, study finds , ,...e fear factor meets the jubilant sports fan. , ... those who root for the winning team -- enjoy the ...match and victory was in doubt, producing feelings... Thanksgiving weekend as you,re glued to the TV se...
(Date:11/26/2009)...mmunications announces a highly effective and unco...ruggling to make an economic recovery. , ...ears is the type of challenge that could send aili...to Dr. David Benton, business growth expert and au...– The Rfactor Intensive . “Fear is ...
(Date:11/25/2009)...Newswire-FirstCall/-- OnyxPharmaceuticals,Inc.(Na...oinvestoreventsinDecember: ,, ASHBriefing ,..., Principalinvestigatorswilldiscussdatapresentati...ymultiplemyeloma,asfeaturedatthe51stAmericanSociet...rleans,LA.Theteleconferencewillbeginat9:00a.m.CT/1...
(Date:11/25/2009)...ewswire-USNewswire/--AnarticlebyJanetWoodcock,M.D....rch,titled"ADifficultBalance-PainManagement,DrugSa...ewEnglandJournalofMedicine. ,, (Logo: http://ww..., Inthearticle,WoodcockdiscussesFDAeffortstostrike...editandmanagingtherisksposedbyvariousanalgesics.As...
(Date:11/25/2009)... cancer who were treated with cisplatin-based chem...eurological side effects and Raynaud-like phenomen..., according to a new study published online Novemb...tute . , Marianne Brydy, M.D., of the Department...rgen, Norway, and colleagues conducted a cross-sec...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...illings , THURSDAY, Sept. 13 (HealthDay News) -- T... to the dentist,s office, according to a team deve...que may be available to dentists and their relieve...hemical reaction to disinfect and prepare cavities...
...s, or fillings, is relatively common knowledge; ho...al system is a debate that has been ongoing for 15... will for the first time study whether prenatal ...levels of mercury exposure, Gene Watson, D.D.S, Ph...
...ily Multi-Vitamins to Young ...s summer Vitamin Relief USA, (http://www.vitaminre...com ) joined Bay St.,Louis-Waveland School Distric... district completely crushed by Hurricane,Katrina,...
...arer, study finds , THURSDAY, Sept. 13 (HealthDay ...r men over 30 have low testosterone levels, but on...linked to such a deficiency. , As men age, they ar...lain. , Low testosterone is defined as 300ng/dL (n...
...of Hurricane Felix, which ripped through the Carib...ernational relief organization, is sending,an emer...p the people,affected in Nicaragua and Honduras. ...as shipped by AmeriCares in preparation for the vi...
...stCall/ - Northstar,Healthcare Inc., (TSX:NHC) ("N...f intent to acquire an option to purchase a 60% in...mbulatory surgical center located at,5920 Forest P... 2007. Northstar,is headquartered in Houston and i...
Other Medicine News:Health News:Coming Soon: Pain-Free Dentistry 2Health News:Most comprehensive study of mercury in dental fillings begins 2Health News:Most comprehensive study of mercury in dental fillings begins 3Health News:Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina 2Health News:Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina 3Health News:Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina 4Health News:Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina 5Health News:1 in 4 Men Over 30 Has Low Testosterone 2Health News:AmeriCares Airlifts Relief to Nicaragua and Honduras 2Health News:Northstar Healthcare Announces Option to Purchase a 60% Interest in The Palladium for Surgery - Dallas 2Health News:Northstar Healthcare Announces Option to Purchase a 60% Interest in The Palladium for Surgery - Dallas 3
IMMULITE/IMMULITE 1000 Cortisol
...ors from KUBTEC represents a stand-alone, high-res...to 16 bit digital interface. The large sensing are... spacing down to 48 microns. All models are availa...ed energy range (10-160 kV). Applications range fr...
...UBTEC is a dual capability system with the ability...on of the specimen under test. While the XCAT seri...X-ray images, the micro focus source also allows t...ard 2D images. The 100 mm x 100 mm digital detecto...
...men radiography. The XPERT represents a research t...n every digital x-ray image, thus being able to ca...ore were lost to the human eye. With features incl...e, multi-color digital operator interface, and a 1...
Medicine Products: